Tammy Lovell

Huma
By  Tammy Lovell 06:36 am May 12, 2021
The funds will be used to scale its remote monitoring platform.
COVID-19 vaccine passport
By  Tammy Lovell 04:53 am May 12, 2021
The NHS app will be used to demonstrate COVID-19 vaccination status
AI, drug discovery, facioscapulohumeral dystrophy
By  Tammy Lovell 01:53 am May 12, 2021
The partnership will work on a drug discovery programme for the genetic muscle wasting disorder.
DiGA
By  Tammy Lovell 12:18 pm May 5, 2021
A white paper from Research2Guidance finds that gaining DiGA approval alone does not ensure the adoption and success of healthcare apps.
Kry, investor, Livi
By  Tammy Lovell 09:27 am April 27, 2021
The investment will be used to fund further European expansion.
OxiFlow
By  Tammy Lovell 06:52 am April 8, 2021
Funding will be used to gain in-human data for startup’s OxiFlow brain haemorrhage solution. 
Series B, funding, Zedsden
By  Tammy Lovell 09:51 am April 6, 2021
The funds will be used to develop the firm’s non-invasive blood sensing technology. 
UV, cleaning robots, covid-19
By  Tammy Lovell 04:05 am April 3, 2021
The sterilisation method has been used in hospitals and laboratories for more than 50 years. 
AI, CE Mark
By  Tammy Lovell 06:45 am April 2, 2021
System which identifies patients at risk of fatal heart attack obtains CE mark. 
Health technology assessment, regulation
By  Tammy Lovell 06:03 am March 31, 2021
Concerns raised that EU Health Technology Assessment Regulation could lead to delays in market approval.